Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients

Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients

BackgroundIncreasing evidence shows that alterations in gut microbiome (GM) contribute to the development of type 2 diabetes mellitus (T2DM), and fecal microbiota transplantation (FMT) successfully treats various human diseases. However, the benefits of FMT therapy to T2DM patients remain unknown.Me...

Full description

Bibliographic Details
Main Authors: Dafa Ding, Huijuan Yong, Na You, Wei Lu, Xu Yang, Xiaolong Ye, Yayun Wang, Tingting Cai, Xiaoling Zheng, Hui Chen, Bota Cui, Faming Zhang, Xingyin Liu, Jian-Hua Mao, Yibing Lu, Hang Chang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
fecal microbiota transplantation
type 2 diabetes mellitus
therapeutic biomarker
prospective cohort study
gut microbiome
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2022.820367/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2022.820367/full

Similar Items